The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

No­var­tis man­u­fac­tur­ing fa­cil­i­ty in North Car­oli­na gets FDA all-clear to pro­duce, ship gene ther­a­pies

4 years ago
Pharma

Boehringer In­gel­heim boosts R&D com­mit­ment, promis­es up to 15 new prod­uct launch­es by 2025

4 years ago
R&D
Pharma

On­tario antes up $580M for C&G ther­a­py plant in Hamil­ton

4 years ago
Pharma

Sanofi's plan to list its API spin­out in France is a go

4 years ago
Pharma

Q&A: Lon­za­'s Chris­t­ian Dowdeswell talks HPA­PIs and the Oas­mia deal

4 years ago

Bay­er to dump $2.26B in­to man­u­fac­tur­ing re­align­ment as it says good­bye to some sites

4 years ago
R&D

AGC to use re­cent­ly-ex­pand­ed Ger­many site for peanut al­ler­gy drug tri­als

4 years ago

In­dia of­fers in­cen­tives to do­mes­tic drug­mak­ers for APIs; Af­ter PhI­II tri­als, Tai­ho li­cens­es Arokaris in Japan

4 years ago

A team at Penn says it has slashed CAR-T cell ther­a­py man­u­fac­tur­ing time­frame to just 24 hours

4 years ago
Pharma
Cell/Gene Tx

Pe­ter Hotez and Maria Bot­tazz­i's 'for­got­ten' vac­cine ap­proved in Botswana

4 years ago
Pharma
Coronavirus

Biden like­ly to sign a bill that would crack down on Chi­na's choke­hold on the an­tibi­ot­ic sup­ply

4 years ago
FDA+

Bel­gian CD­MO of­fers new LNP ser­vice as de­mand for RNA-de­liv­ery ser­vices heats up

4 years ago
Pharma

Jazz plots mas­sive growth for UK cannabi­noid op­er­a­tions

4 years ago
Pharma

In quick turn, ten23 al­ready look­ing to ex­pand Visp fill-fin­ish site

4 years ago
Pharma

Mer­ck to stop mak­ing APIs at Penn­syl­va­nia site and cut 300 jobs by 2024

4 years ago
Pharma

Q&A: In an of­ten-over­looked part of the state, a small Mass­a­chu­setts CMO has its first FDA ap­proval

4 years ago
Pharma

So­bi clos­es out 24-year part­ner­ship with Pfiz­er; Bel­gian Exothera site gets thumbs up from FDA

4 years ago

Takeda's rare dis­ease drug's man­u­fac­tur­ing and sup­ply woes con­tin­ue as FDA re­jects sup­ple­ment

4 years ago
Pharma

Amid in­spec­tion and re­call woes, Au­robindo to shut down NJ site in April

4 years ago
Pharma

Fu­ji­film ex­pands C&G ther­a­py op­tions with ac­qui­si­tion of re­com­bi­nant pro­tein mak­er

4 years ago
Deals
Outsourcing

Serum In­sti­tute lands an­oth­er vac­cine col­lab­o­ra­tion, push­ing busi­ness be­yond the pan­dem­ic

4 years ago
Pharma

Lon­za inks deal with first cus­tomer at re­cent­ly-ex­pand­ed Chi­na man­u­fac­tur­ing site

4 years ago
Pharma

Af­ter ac­qui­si­tions and new deals, Re­cro re­brands to So­ci­etal CD­MO

4 years ago
Pharma

Cadi­la's ster­ile in­jectable site in In­dia hit with a Form 483 fol­low­ing a rare in­ter­na­tion­al in­spec­tion for FDA

4 years ago
FDA+
First page Previous page 55565758596061 Next page Last page
A service from the Financial Times